EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessment a Novel Iron Status Biomarker (Hepcidin) among Patients with Psoriasis

Rabab Raihan Nayyef, Jamal Ahmed Abdul Barry, Hadaf Abdul Amir Aljunaiyeh

University of Thi-Qar Journal Of Medicine · 2024

DOI: 10.32792/jmed.v28i2.579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift University of Thi-Qar Journal Of Medicine, 2024. Verfasst von Rabab Raihan Nayyef und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is a skin disease caused by an overactive immune system, affecting up to 3% of the population. It is characterized by chronic inflammation and excessive growth of skin cells due to interactions between immune cells and skin cells. Recently, researchers have observed connections between psoriasis and other systemic diseases, suggesting that skin inflammation may be related to inflammation throughout the body. Hepcidin is a peptide hormone transcription in the hepatocytes, is a significant iron homeostasis regulator that was just recently identified. The interaction between positive and negative stimulation is crucial in defining the net levels of Hepcidin, even though the iron store and inflammatory regulation activate Hepcidin and hypoxia, anemia, excessive iron load, and enhanced erythropoiesis all adversely control Hepcidin expression.

Methods

In a case-control study, 120 psoriasis patients and 120 seemingly healthy controls matched for age and sex were included., ages ranging from 18-60 years, who attended Al-NasiriyaTeaching Hospital specialized dermatology and venereology consultant from December 2023 to June 2024. five milliliters of blood were drawn via venin puncture. According to the manufacturer's instructions, Hepcidin in serum will be measured using a sandwich enzyme-linked immunosorbent assay (ELISA) kit (Sunlong, China, REF SL0868Hu). and serum hs CRP using routine standard method.Results :The results indicate that the level of serum Hepcidin significantly decreased (P

Zitieren

APA

Nayyef, R. R., Barry, J. A. A., & Aljunaiyeh, H. A. A. (2024). Assessment a Novel Iron Status Biomarker (Hepcidin) among Patients with Psoriasis. University of Thi-Qar Journal Of Medicine. https://doi.org/10.32792/jmed.v28i2.579

Vancouver

Nayyef RR, Barry JAA, Aljunaiyeh HAA. Assessment a Novel Iron Status Biomarker (Hepcidin) among Patients with Psoriasis. University of Thi-Qar Journal Of Medicine. 2024. doi:10.32792/jmed.v28i2.579

BibTeX
@article{Nayyef2024,
  author = {Nayyef, Rabab Raihan and Barry, Jamal Ahmed Abdul and Aljunaiyeh, Hadaf Abdul Amir},
  title = {Assessment a Novel Iron Status Biomarker (Hepcidin) among Patients with Psoriasis},
  journal = {University of Thi-Qar Journal Of Medicine},
  year = {2024},
  doi = {10.32792/jmed.v28i2.579}
}
Kostenlos starten →